Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. annual/quarterly total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Inhibrx Biosciences, Inc. total liabilities for the quarter ending December 31, 2025 were 138.5M, a 193.51% increase year-over-year.
- Inhibrx Biosciences, Inc. total liabilities for 2025 were 138.5M, a 193.51% increase from 2024.
- Inhibrx Biosciences, Inc. total liabilities for 2024 were 47.2M, a 82.15% decrease from 2023.
- Inhibrx Biosciences, Inc. total liabilities for 2023 were 264.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Inhibrx Biosciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $138 |
| 2024 | $47 |
| 2023 | $264 |
| Inhibrx Biosciences, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $138 |
| 2024-12-31 | $47 |
| 2023-12-31 | $264 |
Inhibrx Biosciences, Inc. Total Liabilities — FAQ
Inhibrx Biosciences, Inc. (INBX) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's total liabilities history?
The chart and table above show Inhibrx Biosciences, Inc.'s total liabilities by year and by quarter, including the growth rate.